BRISTOL MYERS SQUIBB
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2006-08-02
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 186
- Registration Number
- NCT00359450
- Locations
- 🇬🇧
Local Institution, Oxford, Oxfordshire, United Kingdom
Drug Interaction Study With Proton Pump Inhibitor
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 56
- Registration Number
- NCT00357240
- Locations
- 🇺🇸
Local Institution, Hamilton, New Jersey, United States
Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects
- Conditions
- HIV InfectionsProtease Inhibitor
- Interventions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 22
- Registration Number
- NCT00357188
- Locations
- 🇺🇸
Local Institution, Hamilton, New Jersey, United States
Atazanavir Twice Daily
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2011-04-06
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 18
- Registration Number
- NCT00357721
- Locations
- 🇺🇸
Local Institution, Hamilton, New Jersey, United States
Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2013-05-15
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00357461
Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females
- Conditions
- HIV Infections
- Interventions
- Drug: Ortho Tri-Cyclen LO (ethinyl estradiol + norgestimate) + Atazanavir/Ritonavir for 14 days then Ortho Tri-Cyclen for 7 daysDrug: Ortho Tri-Cyclen (ethinyl estradiol + norgestimate)
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2011-04-08
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 22
- Registration Number
- NCT00357604
- Locations
- 🇺🇸
Covance Cpu, Inc, San Diego, California, United States
A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer
- First Posted Date
- 2006-07-21
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 137
- Registration Number
- NCT00355238
- Locations
- 🇺🇸
Univ Of Texas Southwestern, Dallas, Texas, United States
🇺🇸Northwestern University Feinberg School Of Medicine, Chicago, Illinois, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF)
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2010-02-17
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 44
- Registration Number
- NCT00352560
- Locations
- 🇪🇸
Local Institution, Madrid, Spain
A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies
- First Posted Date
- 2006-07-12
- Last Posted Date
- 2009-09-04
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 45
- Registration Number
- NCT00351325
- Locations
- 🇺🇸
University Of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States
🇺🇸Magee-Womens Hospital Of Upmc, Pittsburgh, Pennsylvania, United States
🇺🇸University Of Virginia, Charlottesville, Virginia, United States
Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL
- Conditions
- Chronic Myeloid LeukemiaAcute Lymphoblastic Leukemia
- First Posted Date
- 2006-07-07
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Bristol-Myers Squibb
- Registration Number
- NCT00349518
- Locations
- 🇬🇧
Local Institution, Birmingham, West Midlands, United Kingdom
🇵🇱Local Instiution, Lodz, Poland